APO RESEARCH · REPORT
Dental Drug
There are a number of different drugs that dentist may prescribe, depending on patient’s condition. Some medications are prescribed to fight certain oral diseases, to prevent or treat infections, or to control pain and relieve anxiety. The dose of the drugs and instructions on how to take them will differ from patient to patient, depending on what the drug is being used for, patient's age, weight, and other considerations.
Product & engineering
Understand the product.
There are a number of different drugs that dentist may prescribe, depending on patient’s condition. Some medications are prescribed to fight certain oral diseases, to prevent or treat infections, or to control pain and relieve anxiety. The dose of the drugs and instructions on how to take them will differ from patient to patient, depending on what the drug is being used for, patient's age, weight, and other considerations.
Selected research
Industry Research
Dental Drug Industry Research Report 2026
Market perspective
There are a number of different drugs that dentist may prescribe, depending on patient’s condition. Some medications are prescribed to fight certain oral diseases, to prevent or treat infections, or to control pain and relieve anxiety. The dose of the drugs and instructions on how to take them will differ from patient to patient, depending on what the drug is being used for, patient's age, weight, and other considerations.
Global Dental Drug key players include Merck, Bayer, JandJ, GSK, 3M, etc. Global top five players hold a share about 40%.
North America is the largest market, with a share about 35%, followed by Europe and Asia-Pacific, having a total share about 55 percent.
Read the full market overview
In terms of product, OTC is the largest segment, with a share about 60%. And in terms of application, the largest application is Hospitals, followed by Dental Clinics, Drugstores.
Report Scope
This report quantifies the global Dental Drug market in terms of revenue (US$ million) and, where applicable, service volume (MT), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Dental Drug.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Dental Drug Market by Company
Merck
Bayer
JandJ
GSK
3M
Sunstar
Colgate-Palmolive
DenMat
Showa Yakuhin Kako
Bausch Health
Septodont
Roche
PerioChip
Hutchison China MediTech
Xiuzheng Pharmaceutical
Acteon
Xttrium Laboratorie
Mediwin Pharmaceuticals
Dental Drug Segment by Type
OTC
Prescription Product
Dental Drug Segment by Application
Hospitals
Dental Clinics
Drugstores
Dental Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dental Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dental Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dental Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Dental Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- OTC
- Prescription Product
Applications
- Hospitals
- Dental Clinics
- Drugstores
Companies covered
- Merck
- Bayer
- JandJ
- GSK
- 3M
- Sunstar
- Colgate-Palmolive
- DenMat
- Showa Yakuhin Kako
- Bausch Health
- Septodont
- Roche
- PerioChip
- Hutchison China MediTech
- Xiuzheng Pharmaceutical
- Acteon
- Xttrium Laboratorie
- Mediwin Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Dental Drug by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 OTC
- 2.2.3 Prescription Product
- 2.3 Dental Drug by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Dental Clinics
- 2.3.4 Drugstores
- 2.4 Assumptions and Limitations
3 Dental Drug Breakdown Data by Type
- 3.1 Global Dental Drug Historic Market Size by Type (2021-2026)
- 3.2 Global Dental Drug Forecasted Market Size by Type (2027-2032)
4 Dental Drug Breakdown Data by Application
- 4.1 Global Dental Drug Historic Market Size by Application (2021-2026)
- 4.2 Global Dental Drug Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Dental Drug Market Perspective (2021-2032)
- 5.2 Global Dental Drug Growth Trends by Region
- 5.2.1 Global Dental Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Dental Drug Historic Market Size by Region (2021-2026)
- 5.2.3 Dental Drug Forecasted Market Size by Region (2027-2032)
- 5.3 Dental Drug Market Dynamics
- 5.3.1 Dental Drug Industry Trends
- 5.3.2 Dental Drug Market Drivers
- 5.3.3 Dental Drug Market Challenges
- 5.3.4 Dental Drug Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Dental Drug Players by Revenue
- 6.1.1 Global Top Dental Drug Players by Revenue (2021-2026)
- 6.1.2 Global Dental Drug Revenue Market Share by Players (2021-2026)
- 6.2 Global Dental Drug Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Dental Drug Head Office and Area Served
- 6.4 Global Dental Drug Players, Product Type & Application
- 6.5 Global Dental Drug Manufacturers Established Date
- 6.6 Global Dental Drug Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Dental Drug Market Size (2021-2032)
- 7.2 North America Dental Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Dental Drug Market Size by Country (2021-2026)
- 7.4 North America Dental Drug Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Dental Drug Market Size (2021-2032)
- 8.2 Europe Dental Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Dental Drug Market Size by Country (2021-2026)
- 8.4 Europe Dental Drug Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Dental Drug Market Size (2021-2032)
- 9.2 Asia-Pacific Dental Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Dental Drug Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Dental Drug Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Dental Drug Market Size (2021-2032)
- 10.2 South America Dental Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Dental Drug Market Size by Country (2021-2026)
- 10.4 South America Dental Drug Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Dental Drug Market Size (2021-2032)
- 11.2 Middle East & Africa Dental Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Dental Drug Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Dental Drug Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Merck
- 12.1.1 Merck Company Information
- 12.1.2 Merck Business Overview
- 12.1.3 Merck Revenue in Dental Drug Business (2021-2026)
- 12.1.4 Merck Dental Drug Product Portfolio
- 12.1.5 Merck Recent Developments
- 12.2 Bayer
- 12.2.1 Bayer Company Information
- 12.2.2 Bayer Business Overview
- 12.2.3 Bayer Revenue in Dental Drug Business (2021-2026)
- 12.2.4 Bayer Dental Drug Product Portfolio
- 12.2.5 Bayer Recent Developments
- 12.3 JandJ
- 12.3.1 JandJ Company Information
- 12.3.2 JandJ Business Overview
- 12.3.3 JandJ Revenue in Dental Drug Business (2021-2026)
- 12.3.4 JandJ Dental Drug Product Portfolio
- 12.3.5 JandJ Recent Developments
- 12.4 GSK
- 12.4.1 GSK Company Information
- 12.4.2 GSK Business Overview
- 12.4.3 GSK Revenue in Dental Drug Business (2021-2026)
- 12.4.4 GSK Dental Drug Product Portfolio
- 12.4.5 GSK Recent Developments
- 12.5 3M
- 12.5.1 3M Company Information
- 12.5.2 3M Business Overview
- 12.5.3 3M Revenue in Dental Drug Business (2021-2026)
- 12.5.4 3M Dental Drug Product Portfolio
- 12.5.5 3M Recent Developments
- 12.6 Sunstar
- 12.6.1 Sunstar Company Information
- 12.6.2 Sunstar Business Overview
- 12.6.3 Sunstar Revenue in Dental Drug Business (2021-2026)
- 12.6.4 Sunstar Dental Drug Product Portfolio
- 12.6.5 Sunstar Recent Developments
- 12.7 Colgate-Palmolive
- 12.7.1 Colgate-Palmolive Company Information
- 12.7.2 Colgate-Palmolive Business Overview
- 12.7.3 Colgate-Palmolive Revenue in Dental Drug Business (2021-2026)
- 12.7.4 Colgate-Palmolive Dental Drug Product Portfolio
- 12.7.5 Colgate-Palmolive Recent Developments
- 12.8 DenMat
- 12.8.1 DenMat Company Information
- 12.8.2 DenMat Business Overview
- 12.8.3 DenMat Revenue in Dental Drug Business (2021-2026)
- 12.8.4 DenMat Dental Drug Product Portfolio
- 12.8.5 DenMat Recent Developments
- 12.9 Showa Yakuhin Kako
- 12.9.1 Showa Yakuhin Kako Company Information
- 12.9.2 Showa Yakuhin Kako Business Overview
- 12.9.3 Showa Yakuhin Kako Revenue in Dental Drug Business (2021-2026)
- 12.9.4 Showa Yakuhin Kako Dental Drug Product Portfolio
- 12.9.5 Showa Yakuhin Kako Recent Developments
- 12.10 Bausch Health
- 12.10.1 Bausch Health Company Information
- 12.10.2 Bausch Health Business Overview
- 12.10.3 Bausch Health Revenue in Dental Drug Business (2021-2026)
- 12.10.4 Bausch Health Dental Drug Product Portfolio
- 12.10.5 Bausch Health Recent Developments
- 12.11 Septodont
- 12.11.1 Septodont Company Information
- 12.11.2 Septodont Business Overview
- 12.11.3 Septodont Revenue in Dental Drug Business (2021-2026)
- 12.11.4 Septodont Dental Drug Product Portfolio
- 12.11.5 Septodont Recent Developments
- 12.12 Roche
- 12.12.1 Roche Company Information
- 12.12.2 Roche Business Overview
- 12.12.3 Roche Revenue in Dental Drug Business (2021-2026)
- 12.12.4 Roche Dental Drug Product Portfolio
- 12.12.5 Roche Recent Developments
- 12.13 PerioChip
- 12.13.1 PerioChip Company Information
- 12.13.2 PerioChip Business Overview
- 12.13.3 PerioChip Revenue in Dental Drug Business (2021-2026)
- 12.13.4 PerioChip Dental Drug Product Portfolio
- 12.13.5 PerioChip Recent Developments
- 12.14 Hutchison China MediTech
- 12.14.1 Hutchison China MediTech Company Information
- 12.14.2 Hutchison China MediTech Business Overview
- 12.14.3 Hutchison China MediTech Revenue in Dental Drug Business (2021-2026)
- 12.14.4 Hutchison China MediTech Dental Drug Product Portfolio
- 12.14.5 Hutchison China MediTech Recent Developments
- 12.15 Xiuzheng Pharmaceutical
- 12.15.1 Xiuzheng Pharmaceutical Company Information
- 12.15.2 Xiuzheng Pharmaceutical Business Overview
- 12.15.3 Xiuzheng Pharmaceutical Revenue in Dental Drug Business (2021-2026)
- 12.15.4 Xiuzheng Pharmaceutical Dental Drug Product Portfolio
- 12.15.5 Xiuzheng Pharmaceutical Recent Developments
- 12.16 Acteon
- 12.16.1 Acteon Company Information
- 12.16.2 Acteon Business Overview
- 12.16.3 Acteon Revenue in Dental Drug Business (2021-2026)
- 12.16.4 Acteon Dental Drug Product Portfolio
- 12.16.5 Acteon Recent Developments
- 12.17 Xttrium Laboratorie
- 12.17.1 Xttrium Laboratorie Company Information
- 12.17.2 Xttrium Laboratorie Business Overview
- 12.17.3 Xttrium Laboratorie Revenue in Dental Drug Business (2021-2026)
- 12.17.4 Xttrium Laboratorie Dental Drug Product Portfolio
- 12.17.5 Xttrium Laboratorie Recent Developments
- 12.18 Mediwin Pharmaceuticals
- 12.18.1 Mediwin Pharmaceuticals Company Information
- 12.18.2 Mediwin Pharmaceuticals Business Overview
- 12.18.3 Mediwin Pharmaceuticals Revenue in Dental Drug Business (2021-2026)
- 12.18.4 Mediwin Pharmaceuticals Dental Drug Product Portfolio
- 12.18.5 Mediwin Pharmaceuticals Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst